At T0, COVID-19 led to a significant increase of CD27-IgD- DNM cells and decrease of CD27+IgD+ USM B-cell frequency in patients with moderate and severe disease, while classical memory B-cell percentage tended to decrease only in patients affected by severe disease (Figure 3A). The gene discussed is CD27; the disease is COVID-19.